Consultadoria & Servicos SDC Unipessoal LDA Chaumiere

CIK 1330564 · last filed 2010-07-01

Consultadoria & Servicos SDC Unipessoal LDA Chaumiere is a corporate insider who has filed 7 SEC Form 4 insider transactions across 2 companies since 2008. The most recent filing, for SCLN, was dated Jul 1, 2010. Across all open-market trades the lifetime net is −$1.6M, making them a net seller over the disclosed history. 6 SEC filings were submitted jointly with S P A APTAFIN.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$0

Companies

2

Total Filings

7

Lifetime Open-Market Net

-$1.60M

Filer Profile

Reported Address

77-6F AVENIDA ARRIAGA
EDIFICIO MARINA FORUM
FUNCHAL-MADEIRA, S1 P-9000

Phone

351 291 20 24 00

State of Incorporation

Portugal

Related Filers

S P A APTAFIN — 6 joint filings, latest 2008-08-14

PAOLO CAVAZZA — 6 joint filings, latest 2008-08-14

CLAUDIO CAVAZZA — 2 joint filings, latest 2007-11-23

FARMACEUTICA LDA DEFIANTE — 2 joint filings, latest 2007-11-23

SPA Essetifin — 2 joint filings, latest 2007-11-23

Consultadoria & Servicos L.D.A. Inverlochy — 2 joint filings, latest 2007-11-23

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
SCICLONE PHARMACEUTICALS INC (SCLN) Delisted		0	—	—	$0	1	2010-07-01
QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted	10%+ Owner	7,108,889	—	—	-$1.60M	2	2008-07-18

Recent Filings

7 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2010-07-01	SCICLONE PHARMACEUTICALS INC (SCLN) Delisted	Other (J)	−1,289,052	$0	EDGAR
2009-10-13	—	Mixed	+1,219,512	$1000.0K
2009-06-04	—	Buy (P)	+312,500	$125.0K
2009-04-15	—	Mixed	+1,052,631	$600.0K
2008-12-12	—	Mixed	+1,034,482	$1.50M
2008-07-18	QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted	Sell (S)	−300,000	-$1.47M	EDGAR
2008-06-09	QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted	Sell (S)	−24,000	-$124.8K	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.